rs145708952

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_153240.5(NPHP3):​c.3812+42C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00804 in 1,112,508 control chromosomes in the GnomAD database, including 51 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0059 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0084 ( 49 hom. )

Consequence

NPHP3
NM_153240.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.157

Publications

0 publications found
Variant links:
Genes affected
NPHP3 (HGNC:7907): (nephrocystin 3) This gene encodes a protein containing a coiled-coil (CC) domain, a tubulin-tyrosine ligase (TTL) domain, and a tetratrico peptide repeat (TPR) domain. The encoded protein interacts with nephrocystin, it is required for normal ciliary development, and it functions in renal tubular development. Mutations in this gene are associated with nephronophthisis type 3, and also with renal-hepatic-pancreatic dysplasia, and Meckel syndrome type 7. Naturally occurring read-through transcripts exist between this gene and the downstream ACAD11 (acyl-CoA dehydrogenase family, member 11) gene. [provided by RefSeq, Feb 2011]
NPHP3-ACAD11 (HGNC:48351): (NPHP3-ACAD11 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring NPHP3 (nephronophthisis 3, adolescent) and ACAD11 (acyl-CoA dehydrogenase family, member 11) genes on chromosome 3. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus unlikely to produce a protein product. [provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 3-132682661-G-A is Benign according to our data. Variant chr3-132682661-G-A is described in ClinVar as Benign. ClinVar VariationId is 262711.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0059 (897/152134) while in subpopulation NFE AF = 0.00941 (640/67978). AF 95% confidence interval is 0.00881. There are 2 homozygotes in GnomAd4. There are 446 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NPHP3NM_153240.5 linkc.3812+42C>T intron_variant Intron 26 of 26 ENST00000337331.10 NP_694972.3 Q7Z494-1
NPHP3-ACAD11NR_037804.1 linkn.3818+42C>T intron_variant Intron 25 of 44

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NPHP3ENST00000337331.10 linkc.3812+42C>T intron_variant Intron 26 of 26 1 NM_153240.5 ENSP00000338766.5 Q7Z494-1
NPHP3-ACAD11ENST00000632629.1 linkc.458+42C>T intron_variant Intron 3 of 4 2 ENSP00000488520.1 A0A0J9YXS1

Frequencies

GnomAD3 genomes
AF:
0.00589
AC:
896
AN:
152018
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00155
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00433
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00828
Gnomad FIN
AF:
0.00748
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00941
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00664
AC:
1659
AN:
249902
AF XY:
0.00691
show subpopulations
Gnomad AFR exome
AF:
0.00124
Gnomad AMR exome
AF:
0.00227
Gnomad ASJ exome
AF:
0.000896
Gnomad EAS exome
AF:
0.0000548
Gnomad FIN exome
AF:
0.00551
Gnomad NFE exome
AF:
0.0105
Gnomad OTH exome
AF:
0.00345
GnomAD4 exome
AF:
0.00838
AC:
8051
AN:
960374
Hom.:
49
Cov.:
13
AF XY:
0.00837
AC XY:
4186
AN XY:
499872
show subpopulations
African (AFR)
AF:
0.00147
AC:
35
AN:
23882
American (AMR)
AF:
0.00218
AC:
96
AN:
44012
Ashkenazi Jewish (ASJ)
AF:
0.000869
AC:
20
AN:
23004
East Asian (EAS)
AF:
0.0000538
AC:
2
AN:
37194
South Asian (SAS)
AF:
0.00800
AC:
608
AN:
75972
European-Finnish (FIN)
AF:
0.00492
AC:
262
AN:
53210
Middle Eastern (MID)
AF:
0.00185
AC:
9
AN:
4852
European-Non Finnish (NFE)
AF:
0.0103
AC:
6735
AN:
654470
Other (OTH)
AF:
0.00649
AC:
284
AN:
43778
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
420
840
1259
1679
2099
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
178
356
534
712
890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00590
AC:
897
AN:
152134
Hom.:
2
Cov.:
33
AF XY:
0.00599
AC XY:
446
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.00154
AC:
64
AN:
41526
American (AMR)
AF:
0.00432
AC:
66
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00850
AC:
41
AN:
4824
European-Finnish (FIN)
AF:
0.00748
AC:
79
AN:
10566
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00941
AC:
640
AN:
67978
Other (OTH)
AF:
0.00284
AC:
6
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
45
90
136
181
226
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00739
Hom.:
1
Bravo
AF:
0.00532
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.3
DANN
Benign
0.32
PhyloP100
0.16
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145708952; hg19: chr3-132401505; API